A Comparative Study of Normalized Residual Activity and Standard Parameters in 99mTc-DTPA Diuretic Renography:
Improving Obstruction Diagnosis in 99mTc-DTPA Diuretic Renography: A Comparative Study of Normalized Residual Activity and Standard Parameters
調査の概要
詳細な説明
Urinary tract obstruction is a common clinical condition encountered in both pediatric and adult populations and represents a significant cause of potentially reversible renal impairment. Persistent obstruction to urinary outflow may result in progressive deterioration of renal function, recurrent urinary tract infections, nephrolithiasis, hypertension, and ultimately irreversible renal damage if diagnosis and appropriate intervention are delayed. Consequently, early identification of clinically significant obstruction is essential to preserve renal function and optimize patient outcomes. However, differentiating true functional obstruction from non-obstructive dilatation remains one of the major diagnostic challenges in daily clinical practice, particularly in patients presenting with hydronephrosis detected by ultrasonography or other anatomical imaging modalities. (1-3) Although ultrasonography, computed tomography (CT), and magnetic resonance urography provide excellent anatomical information regarding the urinary collecting system, they cannot always determine whether dilatation is associated with functionally significant obstruction. Hydronephrosis may occur in the absence of obstruction due to physiological or congenital causes, including an extrarenal pelvis, non-obstructive pelvicalyceal dilatation, vesicoureteral reflux, or postoperative changes. Therefore, anatomical imaging alone is frequently insufficient for determining the need for surgical intervention, emphasizing the importance of functional assessment of urinary drainage. (1-3)
Diuretic renography has become the established functional imaging technique for evaluating suspected urinary tract obstruction. It provides simultaneous assessment of renal perfusion, differential renal function, and urinary drainage after pharmacologically induced diuresis, thereby enabling distinction between obstructive and non-obstructive dilatation. Among the radiopharmaceuticals used in renal scintigraphy, 99mTc-diethylenetriamine pentaacetic acid (99mTc-DTPA) remains widely used because it is eliminated exclusively by glomerular filtration, allowing for the estimation of glomerular filtration rate (GFR) in addition to assessing urinary drainage within a single examination. (1,4)
Interpretation of diuretic renography has traditionally relied on several qualitative and quantitative parameters, including visual assessment of the renogram curve, time to peak activity (Tmax), half-time of tracer clearance (T½), post-diuretic washout, and differential renal function. Although these parameters remain fundamental components of routine clinical practice, each has recognized limitations. Factors such as impaired renal function, severe pelvicalyceal dilatation, inadequate hydration, bladder distension, patient motion, and variations in diuretic administration protocols may significantly influence tracer washout and reduce diagnostic accuracy. Consequently, equivocal or false-positive interpretations may occur, particularly in markedly dilated but non-obstructed collecting systems. (1,4,7)
To overcome these limitations, several alternative quantitative indices have been proposed to improve the assessment of urinary drainage. One of the most promising parameters is Normalized Residual Activity (NORA), which represents the proportion of residual renal tracer activity at a specified time relative to the initial renal uptake. Unlike conventional washout measurements, NORA is less dependent on renal function and collecting system compliance and provides a simple quantitative estimate of residual tracer retention. Previous investigations have demonstrated that NORA improves discrimination between true urinary tract obstruction and non-obstructive dilatation, particularly when measured on post-micturition images. (5-7)
Recent evidence has suggested that NORA demonstrates superior diagnostic specificity compared with conventional renographic interpretation, reducing the number of equivocal examinations and minimizing unnecessary surgical intervention. Beatović et al. reported that post-micturition NORA correctly reclassified the majority of indeterminate or false-positive renographic studies while maintaining excellent diagnostic accuracy for urinary outflow obstruction. Such findings support the incorporation of quantitative drainage parameters into routine renographic interpretation; however, the clinical utility of NORA has not yet been universally adopted and remains insufficiently evaluated across different patient populations and imaging protocols. (5,7)
Given the continuing reliance on conventional renographic parameters in many nuclear medicine departments and the increasing interest in quantitative assessment of renal drainage, further evaluation of NORA is warranted. Comparing NORA with established renographic indices may
provide additional evidence regarding its diagnostic value and its potential role in improving the accuracy of diuretic renography for patients with suspected urinary tract obstruction. Therefore, the present study aims to compare the diagnostic performance of Normalized Residual Activity with conventional renographic parameters in 99mTc-DTPA diuretic renography for the diagnosis of urinary tract obstruction.
Additionally, Cortical Transit Time (CTT) is an effective metric for distinguishing between obstructed and non-obstructed kidneys. A delayed CTT flags kidneys at risk of functional deterioration if surgery is delayed, whereas a normal CTT signals that the kidney is safe from decline, independent of T_(1/2) values or drainage curve patterns. Ultimately, a normal CTT rules out obstruction as effectively as a favorable diuretic renogram drainage pattern [1].
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Mahytab Abdelhafez Ezzat, Bachelor
- 電話番号:0201096549745
- メール:mahytababdelhafezmaster@gmail.com
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
Patients fulfilling all of the following criteria will be eligible for inclusion:
- Pediatric or adult patients referred for 99mTc-DTPA diuretic renography because of suspected urinary tract obstruction.
- Availability of a clinical reference standard (e.g., confirmation of obstruction via surgical findings/pyeloplasty, or proven non-obstruction via stable long-term clinical and radiological follow-up of at least 6-12 months).
Exclusion Criteria:
Patients meeting any of the following criteria will be excluded:
- Patients with severe renal impairment.
- Patients with renal congenital anomalies e.g. horseshoe kidneys
- Technical failure during the scan, including severe patient motion artifacts or failure to properly administer the diuretic
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Diagnostic performance of Normalized Residual Activity (NORA) Versus conventional renographic parameters in 99mTc-DTPA diuretic renography in the diagnosis of urinary tract obstruction.
時間枠:approximately 2 years
|
approximately 2 years
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
• The ability of NORA to differentiate true urinary tract obstruction from non-obstructive urinary tract dilatation.
時間枠:approximately 2 years
|
approximately 2 years
|
|
Clinical usefulness of incorporating NORA into the routine interpretation of 99mTc-DTPA diuretic renography.
時間枠:approximately 2 years
|
approximately 2 years
|
|
The Predictive value of cortical transit time "CTT" for the deterioration in the function of the hydronephrotic kidney.
時間枠:approximately 2 years
|
approximately 2 years
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Jochumsen MR, Bouchelouche K. PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview. Semin Nucl Med. 2024 Jan;54(1):39-45. doi: 10.1053/j.semnuclmed.2023.07.001. Epub 2023 Jul 22.
- Farrell MB, Banks KP, Peacock JG. Diuretic Renal Scintigraphy. J Nucl Med Technol. 2022 Dec 7;50(4):319-321. doi: 10.2967/jnmt.122.264804. No abstract available.
- Taylor AT, Brandon DC, de Palma D, Blaufox MD, Durand E, Erbas B, Grant SF, Hilson AJW, Morsing A. SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0. Semin Nucl Med. 2018 Jul;48(4):377-390. doi: 10.1053/j.semnuclmed.2018.02.010. Epub 2018 Mar 16. No abstract available.
- Expert Panel on Gastrointestinal Imaging; Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria(R) Chronic Liver Disease. J Am Coll Radiol. 2020 May;17(5S):S70-S80. doi: 10.1016/j.jacr.2020.01.023.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- NORA in diuretic renography
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。